Evaluation of anti-inflammatory impact of dexamethasone-loaded PCL-PEG-PCL micelles on endotoxin-induced uveitis in rabbits

References

• Abrishami M, Ganavati SZ, Soroush D, Rouhbakhsh M, Jaafari MR, Malaekeh-Nikouei B. 2009. Preparation, characterization, and in vivo evaluation of nanoliposomes-encapsulated bevacizumab (avastin) for intravitreal administration. Retina. 29:699–703.
   PubMed Web of Science ®Google Scholar
• Adibkia K, Siahi Shadbad MR, Nokhodchi A, Javadzedeh A, Barzegar-Jalali M, Barar J, Mohammadi G, Omidi Y. 2007. Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis. J Drug Target. 15:407–416.
   PubMed Web of Science ®Google Scholar
• Alami-Milani M, Zakeri-Milani P, Valizadeh H, Salehi R, Jelvehgari M. 2018. Preparation and evaluation of PCL-PEG-PCL micelles as potential nanocarriers for ocular delivery of dexamethasone. Iran J Basic Med Sci. 21:153–164.
   PubMed Web of Science ®Google Scholar
• Alami-Milani M, Zakeri-Milani P, Valizadeh H, Salehi R, Salatin S, Naderinia A, Jelvehgari M. 2017. Novel pentablock copolymers as thermosensitive self-assembling micelles for ocular drug delivery. Adv Pharm Bull. 7:11–20.
   PubMed Web of Science ®Google Scholar
• Ali HS, York P, Ali AM, Blagden N. 2011. Hydrocortisone nanosuspensions for ophthalmic delivery: a comparative study between microfluidic nanoprecipitation and wet milling. J Control Release. 149:175–181.
   PubMed Web of Science ®Google Scholar
• Ammar H, Salama H, Ghorab M, Mahmoud A. 2010. Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery. Drug Dev Ind Pharm. 36:1330–1339.
   PubMed Web of Science ®Google Scholar
• Baatz H, Pleyer U. 2001. Modulation of leukocyte-endothelium interaction by nitric oxide synthase inhibitors: effects on leukocyte adhesion in endotoxin-induced uveitis. Inflamm Res. 50:534–543.
   PubMed Web of Science ®Google Scholar
• Bahuguna A, Khan I, Bajpai VK, Chul S. 2017. MTT assay to evaluate the cytotoxic potential of a drug. Bangladesh J Pharmacol. 12:115–118.
   Web of Science ®Google Scholar
• Bandello F, Parravano M, Cavallero E, Cascavilla ML, Triolo G, Querques L, Borrelli E, Giorno P, Varano M, Lattanzio R, et al. 2015. Prospective evaluation of morphological and functional changes after repeated intravitreal dexamethasone implant (Ozurdex(R)) for retinal vein occlusion. Ophthalmic Res. 53:207–216.
   PubMed Web of Science ®Google Scholar
• Barbosa Saliba J, Vieira L, Fernandes-Cunha GM, Rodrigues Da Silva G, Ligorio Fialho S, Silva-Cunha A, Bousquet E, Naud MC, Ayres E, Orefice RL, et al. 2016. Anti-inflammatory effect of dexamethasone controlled released from anterior suprachoroidal polyurethane implants on endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci. 57:1671–1679.
   PubMed Web of Science ®Google Scholar
• Behar-Cohen FF, Parel JM, Pouliquen Y, Thillaye-Goldenberg B, Goureau O, Heydolph S, Courtois Y, De Kozak Y. 1997. Iontophoresis of dexamethasone in the treatment of endotoxin-induced-uveitis in rats. Exp Eye Res. 65:533–545.
   PubMed Web of Science ®Google Scholar
• Foster KA, Yazdanian M, Audus KL. 2001. Microparticulate uptake mechanisms of in‐vitro cell culture models of the respiratory epithelium. J Pharm Pharmacol. 53:57–66.
   PubMed Web of Science ®Google Scholar
• Goncu T, Oguz E, Sezen H, Kocarslan S, Oguz H, Akal A, Adibelli FM, Cakmak S, Aksoy N. 2016. Anti-inflammatory effect of lycopene on endotoxin-induced uveitis in rats. Arq Bras Oftalmol. 79:357–362.
   PubMed Web of Science ®Google Scholar
• Gong C, Wang Y, Wang X, Wei X, Wu Q, Wang B, Dong P, Chen L, Luo F, Qian Z. 2011. Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic drug delivery, part 2: in vitro and in vivo toxicity evaluation. J Nanopart Res. 13:721–731.
   Web of Science ®Google Scholar
• Gong C, Wei X, Wang X, Wang Y, Guo G, Mao Y, Luo F, Qian Z. 2010. Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic honokiol delivery: I. Preparation and characterization. Nanotechnology. 21:215103.
   PubMed Web of Science ®Google Scholar
• Goureau O, Bellot J, Thillaye B, Courtois Y, de Kozak Y. 1995. Increased nitric oxide production in endotoxin-induced uveitis. Reduction of uveitis by an inhibitor of nitric oxide synthase. J Immunol. 154:6518–6523.
   PubMed Web of Science ®Google Scholar
• Gupta SK, Agarwal R, Srivastava S, Agarwal P, Agrawal SS, Saxena R, Galpalli N. 2008. The anti-inflammatory effects of Curcuma longa and Berberis aristata in endotoxin-induced uveitis in rabbits. Invest Ophthalmol Vis Sci. 49:4036–4040.
   PubMed Web of Science ®Google Scholar
• Herrero-Vanrell R, Cardillo JA, Kuppermann BD. 2011. Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema. Clin Ophthalmol. 5:139–146.
   PubMedGoogle Scholar
• Hogan MJ, Kimura SJ, Thygeson P. 1959. Signs and symptoms of uveitis*: I. anterior uveitis. Am J Ophthalmol. 47:155–170.
   PubMed Web of Science ®Google Scholar
• Hsu YR, Chang SW, Lin YC, Yang CH. 2015. Expression of microRNAs in the eyes of lewis rats with experimental autoimmune anterior uveitis. Mediators Inflamm. 2015:1–11.
   Google Scholar
• Je HJ, Kim ES, Lee JS, Lee HG. 2017. Release properties and cellular uptake in caco-2 cells of size-controlled chitosan nanoparticles. J Agric Food Chem. 65:10899–10906.
   PubMed Web of Science ®Google Scholar
• Joseph RR, Venkatraman SS. 2017. Drug delivery to the eye: what benefits do nanocarriers offer? Nanomedicine (Lond). 12:683–702.
   PubMed Web of Science ®Google Scholar
• Kalam MA, Sultana Y, Ali A, Aqil M, Mishra AK, Chuttani K. 2010. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system. J Drug Target. 18:191–204.
   PubMed Web of Science ®Google Scholar
• Kamata K, Inazu M, Takeda H, Goto H, Matsumiya T, Usui M. 2003. Effect of a selective inducible nitric oxide synthase inhibitor on intraocular nitric oxide production in endotoxin-induced uveitis rabbits: in vivo intraocular microdialysis study. Pharmacol Res. 47:485–491.
   PubMed Web of Science ®Google Scholar
• Karki S, Kim H, Na S-J, Shin D, Jo K, Lee J. 2016. Thin films as an emerging platform for drug delivery. Asian J Pharm. 11:559–574.
   Google Scholar
• Li R, Li X, Xie L, Ding D, Hu Y, Qian X, Yu L, Ding Y, Jiang X, Liu B. 2009. Preparation and evaluation of PEG–PCL nanoparticles for local tetradrine delivery. Int J Pharm. 379:158–166.
   PubMed Web of Science ®Google Scholar
• Li X, Schumann C, Albarqi HA, Lee CJ, Alani AW, Bracha S, Milovancev M, Taratula O, Taratula O. 2018. A tumor-activatable theranostic nanomedicine platform for NIR fluorescence-guided surgery and combinatorial phototherapy. Theranostics. 8:767.
   PubMed Web of Science ®Google Scholar
• Lim S-W, Loh H-S, Ting K-N, Bradshaw TD, Allaudin ZN. 2015. Reduction of MTT to purple formazan by vitamin E isomers in the absence of cells. Trop Life Sci Res. 26:111.
   PubMedGoogle Scholar
• Lima JBM, Veloso CC, Vilela FC, Giusti-Paiva A. 2017. Prostaglandins mediate zymosan-induced sickness behavior in mice. J Physiol Sci. 67:673–679.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Hreinsdóttir D, Stefánsson E. 2007. Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops. J Pharm Pharmacol. 59:629–635.
   PubMed Web of Science ®Google Scholar
• Mandai M, Yoshimura N, Yoshida M, Iwaki M, Honda Y. 1994. The role of nitric oxide synthase in endotoxin-induced uveitis: effects of NG-nitro L-arginine. Invest Ophthalmol Vis Sci. 35:3673–3680.
   PubMed Web of Science ®Google Scholar
• Morrison PW, Connon CJ, Khutoryanskiy VV. 2013. Cyclodextrin-mediated enhancement of riboflavin solubility and corneal permeability. Mol Pharmaceutics. 10:756–762.
   PubMed Web of Science ®Google Scholar
• Mourya V, Inamdar N, Nawale R, Kulthe S. 2011. Polymeric micelles: general considerations and their applications. Ind J Pharm Edu Res. 45:128–138.
   Web of Science ®Google Scholar
• Nguyen THA, Nguyen VC. 2010. Formation of nanoparticles in aqueous solution from poly (ε-caprolactone)–poly (ethylene glycol)–poly (ε-caprolactone). Adv Nat Sci: Nanosci Nanotechnol. 1: 025012.
   Google Scholar
• Noye J, George J, Aymard B, Berrod J, Guedenet J, Raspiller A. 1989. Evaluation of the histopathologic effects following subconjunctival injection of corticoids in immediate-and retard-action forms. J Fr Ophtalmol. 12:587–594.
   PubMedGoogle Scholar
• Nussenblatt RB, Calogero D, Buchen SY, Leder HA, Goodkin M, Eydelman MB. 2012. Rabbit intraocular reactivity to endotoxin measured by slit-lamp biomicroscopy and laser flare photometry. Ophthalmology. 119:e19–e23.
   PubMed Web of Science ®Google Scholar
• Ohia EO, Mancino M, Kulkarni PS. 1992. Effects of steroids and immunosuppressive drugs on endotoxin-uveitis in rabbits. J Ocul Pharmacol. 8:295–307.
   PubMedGoogle Scholar
• Pagano G, Bruno A, Cavallo-Perin P, Cesco L, Imbimbo B. 1989. Glucose intolerance after short-term administration of corticosteroids in healthy subjects. Prednisone, deflazacort, and betamethasone. Arch Intern Med. 149:1098–1101.
   PubMedGoogle Scholar
• Pignatello R, Ricupero N, Bucolo C, Maugeri F, Maltese A, Puglisi G. 2006. Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene. AAPS PharmSciTech. 7:E192–E198.
   PubMed Web of Science ®Google Scholar
• Rafie F, Javadzadeh Y, Javadzadeh AR, Ghavidel LA, Jafari B, Moogooee M, Davaran S. 2010. In vivo evaluation of novel nanoparticles containing dexamethasone for ocular drug delivery on rabbit eye. Curr Eye Res. 35:1081–1089.
   PubMed Web of Science ®Google Scholar
• Rupenthal ID, Green CR, Alany RG. 2011. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release. Int J Pharm. 411:69–77.
   PubMed Web of Science ®Google Scholar
• Sabzevari A, Adibkia K, Hashemi H, Hedayatfar A, Mohsenzadeh N, Atyabi F, Ghahremani MH, Dinarvand R. 2013. Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies. Eur J Pharm Biopharm. 84:63–71.
   PubMed Web of Science ®Google Scholar
• Salatin S, Barar J, Barzegar-Jalali M, Adibkia K, Jelvehgari M. 2017. Thermosensitive in situ nanocomposite of rivastigmine hydrogen tartrate as an intranasal delivery system: development, characterization, ex vivo permeation and cellular studies. Colloids Surf B Biointerfaces. 159:629–638.
   PubMed Web of Science ®Google Scholar
• Soltani S, Zakeri-Milani P, Barzegar-Jalali M, Jelvehgari M. 2016. Design of eudragit RL nanoparticles by nanoemulsion method as carriers for ophthalmic drug delivery of ketotifen fumarate. Iran J Basic Med Sci. 19:550–560.
   PubMed Web of Science ®Google Scholar
• Tamboli V, Mishra GP, Mitra AK. 2013. Novel pentablock copolymer (PLA-PCL-PEG-PCL-PLA) based nanoparticles for controlled drug delivery: effect of copolymer compositions on the crystallinity of copolymers and in vitro drug release profile from nanoparticles. Colloid Polym Sci. 291:1235–1245.
   PubMed Web of Science ®Google Scholar
• Tamby JP, Charpigny G, Reinaud P, Martal J. 1993. Phospholipase A2 activity in endometrium from early pregnant and non-pregnant ewes. Prostaglandins. 46:407–415.
   PubMedGoogle Scholar
• Wallner BP, Mattaliano RJ, Hession C, Cate RL, Tizard R, Sinclair LK, Foeller C, Chow EP, Browning JL, Ramachandran KL, et al. 1986. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature. 320:77–81.
   PubMed Web of Science ®Google Scholar
• Weiss AH, Wallace CA, Sherry DD. 1998. Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis. J Pediatr. 133:266–268.
   PubMed Web of Science ®Google Scholar
• Weng Y, Liu J, Jin S, Guo W, Liang X, Hu Z. 2017. Nanotechnology-based strategies for treatment of ocular disease. Acta Pharm Sin B. 7:281–291.
   PubMed Web of Science ®Google Scholar
• Wong CW, Czarny B, Metselaar JM, Ho C, Ng SR, Barathi AV, Storm G, Wong TT. 2018. Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis. Sci Rep. 8:6604.
   PubMed Web of Science ®Google Scholar
• Wu Q, Li G, Deng S, Ouyang L, Li L, Liu L, Luo N, Song X, He G, Gong C, et al. 2014. Enhanced antitumor activity and mechanism of biodegradable polymeric micelles-encapsulated chetomin in both transgenic zebrafish and mouse models. Nanoscale. 6:11940–11952.
   PubMed Web of Science ®Google Scholar
• Xu X, Weng Y, Xu L, Chen H. 2013. Sustained release of Avastin® from polysaccharides cross-linked hydrogels for ocular drug delivery. Int J Biol Macromol. 60:272–276.
   PubMed Web of Science ®Google Scholar
• Yadav UC, Subramanyam S, Ramana KV. 2009. Prevention of endotoxin-induced uveitis in rats by benfotiamine, a lipophilic analogue of vitamin B1. Invest Ophthalmol Vis Sci. 50:2276–2282.
   PubMed Web of Science ®Google Scholar
• Yang G, Wang J, Li D, Zhou S. 2017. Polyanhydride micelles with diverse morphologies for shape-regulated cellular internalization and blood circulation. Regen Biomater. 4:149–157.
   PubMed Web of Science ®Google Scholar
• Zhang L, Chen Z, Wang H, Wu S, Zhao K, Sun H, Kong D, Wang C, Leng X, Zhu D. 2016. Preparation and evaluation of PCL–PEG–PCL polymeric nanoparticles for doxorubicin delivery against breast cancer. RSC Adv. 6:54727–54737.
   Google Scholar
• Zhang Y. 2012. Novel degradablepolymeric materials for biomedical and antibacterial applications. Beijing: Philipps University of Marburg.
   Google Scholar